Harnessing IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in α-synucleinopathies

Harnessing IGF-1 and IL-2 as biomarkers for calcineurin activity to tailor optimal FK506 dosage in α-synucleinopathies

Introduction: Rise in Calcium (Ca2+) and hyperactive Ca2+-dependent phosphatase calcineurin represent two key determinants of a-synuclein (a-syn) pathobiology implicated in Parkinson’s Disease (PD) and other neurodegenerative diseases. Calcineurin activity can be inhibited with FK506, a Food and Dru...

Full description

Bibliographic Details
Main Authors: Sofia Zaichick, Gabriela Caraveo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Molecular Biosciences
Subjects:
α-synuclein
calcineurin
FK506
neuroprotection
biomarkers
IGF-1
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1292555/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2023.1292555/full

Similar Items